ABEL: Type I Error [RSABE / ABEL]

posted by ElMaestro  – Denmark, 2020-09-29 10:41 (383 d 01:43 ago) – Posting: # 21949
Views: 715

» .... (don’t ask for the country):

… in case of a value of 30% < CVRR <45%, it is recommended to check the control of the patient's risk type I error at the level of 5%. If an alpha adjustment is necessary, it is recommended that a BE estimate for the new CI of the T/R ratio be submitted to meet the extended bounds.


That subjunction is correct but not part of the everyday linguistic toolbox of those who do not speak a lot of English. My guess is MHRA or the Irish Medicines Board or it comes from someone who spent a lot of time taking English language classes :-)

Pass or fail!
ElMaestro

Complete thread:

Activity
 Admin contact
21,731 posts in 4,544 threads, 1,543 registered users;
online 10 (0 registered, 10 guests [including 4 identified bots]).
Forum time: Sunday 12:24 CEST (Europe/Vienna)

Be very, very careful what you put into that head,
because you will never, ever get it out.    Thomas Wolsey

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5